Strensiq 80 MG
Ended Awarded Last action
- Contract number
- 36C24526N0739
- Awardee
-
Alexion Pharmaceuticals Inc. UEI DKCXLGANZAN3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $104,650
Award facts
- Contract value 100% obligated
- $104,650.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Carrollton, TX 75010, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a BPA call to Alexion Pharmaceuticals Inc. on July 21, 2026, with a ceiling value of $104,650.40 for the supply of STRENSIQ 80 MG, with ultimate completion on July 23, 2026.
This call is placed under Alexion's single-award Blanket Purchase Agreement with the VA National Acquisition Center, established September 1, 2022, and valued at $4.24 million through August 31, 2026. The BPA operates under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and supports the procurement and delivery of Strensiq to VA medical centers and clinics nationwide.
STRENSIQ is a specialized injectable medication used to treat hypophosphatasia, a rare genetic disorder. Place of performance is Carrollton, Texas. Alexion performs the work directly from its Boston facility.
Quick answers
Who was awarded contract 36C24526N0739?
36C24526N0739 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on July 21, 2026.
How much is contract 36C24526N0739 worth?
The government has obligated $104,650 on 36C24526N0739.
Is contract 36C24526N0739 an order under another contract?
Yes. 36C24526N0739 is a BPA call under 36F79718D0355-36E79722A0026, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0739 competed?
The extent of competition for 36C24526N0739 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award